ASH 2023

Novel science and breakthroughs presented at the 65th ASH Annual Meeting and Exposition, taking place December 9-12, 2023, in San Diego, California.

Detailing the Clinical Characteristics of CLL in Adolescents, Young Adults
Detailing the Clinical Characteristics of CLL in Adolescents, Young Adults
Rob DillardConference Coverage | December 12, 2023
Researchers sought to describe the clinical and sociodemographic characteristics of AYA patients with CLL.
CLL-Directed Treatment Reduces Risk of Richter Transformation
CLL-Directed Treatment Reduces Risk of Richter Transformation
Rob DillardConference Coverage | December 12, 2023
Patients who received CLL/SLL-directed therapies had a lower risk of Richter transformation.
BTK C481 Mutations Higher Among CLL Patients With Longer BTKi Exposure
BTK C481 Mutations Higher Among CLL Patients With Longer BTKi Exposure
Rob DillardConference Coverage | December 12, 2023
The prevalence of BTK C481 mutations might be higher in CLL patients with longer BTKi exposure.
Analyzing Transcriptional Changes in Patients With CLL Starting Venetoclax Therapy
Analyzing Transcriptional Changes in Patients With CLL Starting Venetoclax Therapy
Rob DillardConference Coverage | December 12, 2023
Venetoclax induces a distinct and prominent transcriptional response in patients with chronic lymphocytic leukemia.
Advertisement
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy